Azithromycin targets the bacterial ribosome but can also affect human cells, particularly those involved in protein synthesis. This can be particularly relevant in tissues that are undergoing rapid cell division or have high metabolic activity. The drug binds to the 50S subunit of the bacterial ribosome and inhibits the translocation of peptides, which can indirectly affect human ribosomes due to structural similarities.
